The words, in plain language.
Vasomotor symptoms? GSM? STRAW+10? Here are the key menopause terms defined simply — with a plain "what it means for you" for each.
Stages & tracking
Perimenopause
The transition leading up to menopause, lasting several years on average. Hormone levels (especially estrogen) fluctuate unpredictably, periods become increasingly irregular, and most menopause symptoms begin. Divided into early and late stages based on cycle-length changes. Ends at menopause (the 12-month mark).
Menopause
A single point in time: the day you've gone 12 consecutive months without a period, with no other cause (pregnancy, breastfeeding, medication, illness). After this milestone, you're considered postmenopausal. Average age in the U.S.: 51.
Postmenopause
Everything after menopause — the years and decades following your final period. Hormones stabilize at a low level (the chaotic swings of perimenopause are over), but some symptoms may persist, and long-term health considerations (bone density, cardiovascular health) shift.
STRAW+10
Stages of Reproductive Aging Workshop +10 — the clinical framework doctors use to stage the menopause transition. Based on menstrual cycle patterns (not blood tests), it defines the stages from late reproductive through postmenopause. Updated in 2011.
Hormones & labs
FSH (Follicle-Stimulating Hormone)
A hormone produced by the pituitary gland that stimulates the ovaries. As ovarian function declines, FSH rises — the brain "turning up the volume" to get the ovaries to respond. In perimenopause, FSH can swing dramatically day to day, making a single blood test unreliable for staging.
AMH (Anti-Müllerian Hormone)
A hormone produced by ovarian follicles that reflects your remaining egg supply. AMH declines steadily with age and becomes very low as you approach menopause. Unlike FSH, AMH is relatively stable across the menstrual cycle.
Estradiol
The primary and most potent form of estrogen during your reproductive years. Produced by the ovaries, it cycles monthly during your fertile years. During perimenopause, estradiol swings unpredictably before eventually declining to very low levels after menopause.
Estrone
A weaker form of estrogen, produced primarily in fat tissue from adrenal hormones. After menopause, when the ovaries stop producing meaningful estradiol, estrone becomes your body's main estrogen.
Symptoms
VMS (Vasomotor Symptoms)
The clinical term for hot flashes and night sweats. "Vasomotor" refers to the widening and narrowing of blood vessels involved in temperature regulation. As estrogen fluctuates, the brain's temperature-control center becomes more reactive to small changes, triggering the sudden heat, flushing, and sweating of a hot flash. Affects up to 80% of women during the transition.
GSM (Genitourinary Syndrome of Menopause)
The clinical term for the collection of vaginal, sexual, and urinary symptoms that result from declining estrogen — vaginal dryness, irritation, painful sex (dyspareunia), urinary urgency, leaking, and recurrent UTIs. Unlike hot flashes, GSM tends to persist or worsen over time without treatment.
Dyspareunia
The clinical term for pain during sexual intercourse. In menopause, it's most often caused by GSM — the thinning and drying of vaginal tissues due to low estrogen.
Anhedonia
A reduced ability to feel pleasure or interest in things you normally enjoy — including emotional flatness or a sense of numbness. During perimenopause, anhedonia is linked to fluctuating estrogen's effects on dopamine (the brain's reward and motivation chemical). It's different from sadness — it can feel like the "color" drained out of life.
Window of Opportunity
In hormone therapy, the period during which the benefit-to-risk balance is most favorable: for healthy women under age 60 or within 10 years of their final period. Starting MHT inside this window is associated with cardiovascular benefits and lower absolute risks. Starting more than 10 years after menopause or after 60 shifts the balance.
Treatments
MHT / HRT (Menopausal Hormone Therapy / Hormone Replacement Therapy)
Medication that supplies estrogen (and, for women with a uterus, usually a progestogen to protect the uterine lining) to reduce menopause symptoms. Available as oral pills, skin patches, gels, sprays, and vaginal preparations. Guidelines describe MHT as the most effective treatment for moderate-to-severe hot flashes and night sweats. "HRT" is still widely used but "MHT" is the more current clinical term.
Transdermal Estrogen
Estrogen delivered through the skin — via a patch, gel, or spray — rather than swallowed as a pill. Because it's absorbed directly into the bloodstream, it bypasses the liver, which reduces clotting and cardiovascular risks compared to oral estrogen.
Micronized Progesterone
A form of progesterone chemically identical to the hormone your body produces. Used in MHT to protect the uterine lining in women who still have a uterus. Evidence suggests it has a more favorable breast-cancer and blood-clot profile than older synthetic progestogens.
Fezolinetant (Veozah)
A newer non-hormonal oral medication that targets the brain mechanism behind hot flashes rather than replacing hormones. Trials showed a statistically significant reduction in hot flash frequency, though independent reviewers judged the average benefit modest. Requires liver-enzyme monitoring, and long-term safety data is still limited.
Credentials & scope
NBHWC (National Board for Health & Wellness Coaching)
The national certifying body for health and wellness coaches in the United States. NBC-HWC certification is the gold standard — it requires comprehensive training in physiology, behavior change, and evidence-based practice, passage of a board exam, and adherence to a professional code of ethics and scope of practice.
Scope of Practice
The defined boundaries of what a professional can and cannot do. For health and wellness coaches (NBHWC), the scope includes education, behavior-change support, and accountability — and explicitly excludes diagnosis, treatment, prescribing, and therapy.